<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WT7R29M" height="0" width="0" style="display:none;visibility:hidden">

Building Resilience through Risky Play Practical Tips for Creating Safe Environments

Watch The Full Webinar Now

Join us for an engaging webinar on creating safe and stimulating environments for young children. Our expert panel will provide practical strategies for both practitioners and parents to foster learning and development in early years.

​​​​​​​The agenda includes:

  • Importance of safe yet stimulating environments for young children
  • Understanding the role of risky play in child development
  • Practical tips for creating optimal environments at home and in childcare settings

Dr.Sarah is the CEO and founder of EYES and Quest.
With over 25 years experience of working within the education sector at senior level in the UK and overseas, Sarah set up EYES and later Quest in order to support and promote the quality of education in both the early years and primary sectors.
As well as carrying out the important day to day tasks of running a company, Sarah is very much a hands-on, proactive CEO. She regularly guest speaks at important educational events and conferences around the region, she also delivers a number of CPD courses.

Michelle started her work with children in the early years delivering physical development programmes with her local council in Scotland.
During this time she spent a lot of time in nursery settings and became interested in classroom practice and the way in which children learn and develop so decided to retrain to become an Early Years Practitioner.
​​​During the 15 years in which Michelle has worked in the early years environment she has held senior teaching positions as well as management roles in nursery settings in both Thailand and the UAE.
As General Manager, Michelle is responsible for the day to day running of Quest/EYES office and also teaches and assesses the Level 5 Diploma for Leadership for Children and Young People’s Services (Management Pathway).